GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianhai Health Holdings Ltd (HKSE:00911) » Definitions » Market Cap

Qianhai Health Holdings (HKSE:00911) Market Cap : HK$39.3 Mil (As of Apr. 09, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Qianhai Health Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Qianhai Health Holdings's share price for the quarter that ended in Jun. 2024 was HK$0.28. Qianhai Health Holdings's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 169.4 Mil. Therefore, Qianhai Health Holdings's market cap for the quarter that ended in Jun. 2024 was HK$47.4 Mil.

Qianhai Health Holdings's quarterly market cap declined from Jun. 2023 (HK$77.9 Mil) to Dec. 2023 (HK$62.7 Mil) and declined from Dec. 2023 (HK$62.7 Mil) to Jun. 2024 (HK$47.4 Mil).

Qianhai Health Holdings's annual market cap increased from Dec. 2021 (HK$127.1 Mil) to Dec. 2022 (HK$149.1 Mil) but then declined from Dec. 2022 (HK$149.1 Mil) to Dec. 2023 (HK$62.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Qianhai Health Holdings's Enterprise Value for Today is HK$17.1 Mil.


Qianhai Health Holdings Market Cap Historical Data

The historical data trend for Qianhai Health Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianhai Health Holdings Market Cap Chart

Qianhai Health Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 203.13 127.08 149.11 62.69 49.14

Qianhai Health Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.11 77.94 62.69 47.44 49.14

Competitive Comparison of Qianhai Health Holdings's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Qianhai Health Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianhai Health Holdings's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianhai Health Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Qianhai Health Holdings's Market Cap falls into.


;
;

Qianhai Health Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Qianhai Health Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=HK$0.37*169.445
=HK$62.7

Qianhai Health Holdings's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=HK$0.28*169.445
=HK$47.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qianhai Health Holdings  (HKSE:00911) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Qianhai Health Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Qianhai Health Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianhai Health Holdings Business Description

Traded in Other Exchanges
N/A
Address
177-183 Wing Lok Street, Room 301-3, 3rd Floor, Wing Tuck Commercial Centre, Sheung Wan, Hong Kong, HKG
Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products and the sale of information technology components products. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products includes sale of healthcare products including Chinese herbal medicines, skincare and other healthcare products. Electronic component products includes sale of information technology components products including central processing unit and semiconductors. The group's revenue is all derived from Hong Kong.
Executives
Huang Jinglin 2201 Interest of corporation controlled by you
Chong Siew Hoong 2202 Interest of your spouse
Explorer Rosy Limited
Huang Zhiqun
Hou Chung Man 2501 Other
Huang Guanchao 2101 Beneficial owner
Shinewing Sas (nominee Services) No. 3 Limited 2501 Other
Tang Chung Wah 2501 Other
Sparkling Rock Limited 2201 Interest of corporation controlled by you
Lim Tzea 2101 Beneficial owner
Thousands Beauties Limited
Yunnan Energy Investment (h K) Co. Limited 2106 Person having a security interest in shares
Yunnan International Holding Group Limited 2106 Person having a security interest in shares
Yunnan International Supply Chain Limited 2106 Person having a security interest in shares
Yunnan Provincial Energy Investment Group Co., Ltd 2106 Person having a security interest in shares

Qianhai Health Holdings Headlines

No Headlines